These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8596524)

  • 1. Evaluating the effectiveness of addiction treatments: reasonable expectations, appropriate comparisons.
    McLellan AT; Woody GE; Metzger D; McKay J; Durrell J; Alterman AI; O'Brien CP
    Milbank Q; 1996; 74(1):51-85. PubMed ID: 8596524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance abuse treatment: outcomes of managed care techniques.
    Chung R; Filstead WJ
    Behav Healthc Tomorrow; 1995; 4(6):78-9, 58. PubMed ID: 10172617
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of family-based substance abuse treatment.
    Morgan TB; Crane DR
    J Marital Fam Ther; 2010 Oct; 36(4):486-98. PubMed ID: 21039660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organizational and client determinants of cost in outpatient substance abuse treatment.
    Beaston-Blaakman A; Shepard D; Horgan C; Ritter G
    J Ment Health Policy Econ; 2007 Mar; 10(1):3-13. PubMed ID: 17417043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving drug addiction treatment in China.
    Tang YL; Hao W
    Addiction; 2007 Jul; 102(7):1057-63. PubMed ID: 17567394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Public substance abuse and managed behavioral healthcare. American Managed Behavioral Healthcare Association and National Association of State Alcohol and Drug Abuse Directors, Inc.
    Behav Healthc Tomorrow; 1999 Feb; 8(1):25-30. PubMed ID: 10346117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The quality of highly regarded adolescent substance abuse treatment programs: results of an in-depth national survey.
    Brannigan R; Schackman BR; Falco M; Millman RB
    Arch Pediatr Adolesc Med; 2004 Sep; 158(9):904-9. PubMed ID: 15351757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unmet substance abuse treatment need, health services utilization, and cost: a population-based emergency department study.
    Rockett IR; Putnam SL; Jia H; Chang CF; Smith GS
    Ann Emerg Med; 2005 Feb; 45(2):118-27. PubMed ID: 15671966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year trajectories of health care utilization and cost in a drug and alcohol treatment sample.
    Parthasarathy S; Weisner CM
    Drug Alcohol Depend; 2005 Nov; 80(2):231-40. PubMed ID: 15916868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness.
    Bellack AS; Bennett ME; Gearon JS; Brown CH; Yang Y
    Arch Gen Psychiatry; 2006 Apr; 63(4):426-32. PubMed ID: 16585472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Veterans Affairs facility performance on Washington Circle indicators and casemix-adjusted effectiveness.
    Harris AH; Humphreys K; Finney JW
    J Subst Abuse Treat; 2007 Dec; 33(4):333-9. PubMed ID: 17400416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substance abuse treatment providers' beliefs and objections regarding contingency management: implications for dissemination.
    Kirby KC; Benishek LA; Dugosh KL; Kerwin ME
    Drug Alcohol Depend; 2006 Oct; 85(1):19-27. PubMed ID: 16650657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of an outreach treatment program for inner city crack abusers: compliance, outcome, and client satisfaction.
    Henskens R; Garretsen H; Bongers I; Van Dijk A; Sturmans F
    Subst Use Misuse; 2008; 43(10):1464-75. PubMed ID: 18615321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Managed care and the quality of substance abuse treatment.
    Shepard DS; Daley M; Ritter GA; Hodgkin D; Beinecke RH
    J Ment Health Policy Econ; 2002 Dec; 5(4):163-74. PubMed ID: 14578550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic evaluation of relapse prevention for substance users: treatment settings and health care policy.
    Yamada T; Chen CC; Yamada T
    Adv Health Econ Health Serv Res; 2005; 16():431-50. PubMed ID: 17867251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in spending for substance abuse treatment, 1986-2003.
    Mark TL; Levit KR; Vandivort-Warren R; Coffey RM; Buck JA;
    Health Aff (Millwood); 2007; 26(4):1118-28. PubMed ID: 17630455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spirituality, sense of coherence, and coping responses in women receiving treatment for alcohol and drug addiction.
    Arévalo S; Prado G; Amaro H
    Eval Program Plann; 2008 Feb; 31(1):113-23. PubMed ID: 17825910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-effectiveness of a mixed-gender aftercare program for substance abuse: decomposing measured and unmeasured gender differences.
    Yeom HS; Shepard DS
    J Ment Health Policy Econ; 2007 Dec; 10(4):207-19. PubMed ID: 18166831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A critical review of accounting and economic methods for estimating the costs of addiction treatment.
    Cartwright WS
    J Subst Abuse Treat; 2008 Apr; 34(3):302-10. PubMed ID: 17614244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.